These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 7004519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Gaucher disease: a century of delineation and research. Enzyme replacement therapy: model and clinical studies.
    Beutler E, Dale GL.
    Prog Clin Biol Res; 1982; 95():703-16. PubMed ID: 7122644
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G, Caubel I, Belmatoug N, Billette de Villemeur T, Saudubray JM.
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
    Pastores GM.
    Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
    [Abstract] [Full Text] [Related]

  • 9. Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.
    Brady RO, Pentchev PG, Gal AE, Hibbert SR, Dekaban AS.
    N Engl J Med; 1974 Nov 07; 291(19):989-93. PubMed ID: 4415565
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Large scale purification of glucocerebrosidase from human placentas.
    Dale GL, Beutler E, Fournier P, Blanc P, Liautaud J.
    Birth Defects Orig Artic Ser; 1980 Nov 07; 16(1):33-41. PubMed ID: 6778526
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assay of glucocerebrosidase using a fluorescent analogue of glucocerebroside for the diagnosis of Gaucher disease.
    Midorikawa M, Okada S, Yutaka T, Yabuuchi H, Naoi M, Kiuchi K, Yagi K.
    Biochem Int; 1985 Sep 07; 11(3):327-32. PubMed ID: 4062951
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
    Mizukami H, Mi Y, Wada R, Kono M, Yamashita T, Liu Y, Werth N, Sandhoff R, Sandhoff K, Proia RL.
    J Clin Invest; 2002 May 07; 109(9):1215-21. PubMed ID: 11994410
    [Abstract] [Full Text] [Related]

  • 20. Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation.
    Beutler E, Dale GL, Guinto DE, Kuhl W.
    Proc Natl Acad Sci U S A; 1977 Oct 07; 74(10):4620-3. PubMed ID: 200923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.